Averaging the indicator maps, weighted by sample size, yielded a density of effects map across studies (Figure 2, Panel b
A 50% increase in weight loss compared to semaglutide (22.5% vs 14.9%) seems too large to explain as mere enhancement
The injectable diabetes drug has become popular as a weight loss supplement among celebrities and wealthy elites, including Elon Musk, so much so that it is in short supply for actual diabetics who need it to manage their condition
Patients with poorly controlled diabetes, cardiovascular risk, obesity-related comorbidities, and those facing access barriers should be prioritized
Temperature fluctuations, light exposure, and physical agitation can cause the peptide chains to break down or aggregate, potentially reducing the medication's effectiveness